1.40
price down icon6.67%   -0.10
after-market Handel nachbörslich: 1.40
loading
Schlusskurs vom Vortag:
$1.50
Offen:
$1.52
24-Stunden-Volumen:
252.26K
Relative Volume:
1.28
Marktkapitalisierung:
$75.93M
Einnahmen:
$1.82M
Nettoeinkommen (Verlust:
$-267.63M
KGV:
-0.0694
EPS:
-20.1639
Netto-Cashflow:
$-50.53M
1W Leistung:
-2.78%
1M Leistung:
+0.72%
6M Leistung:
-17.16%
1J Leistung:
-55.84%
1-Tages-Spanne:
Value
$1.3527
$1.54
1-Wochen-Bereich:
Value
$1.3527
$1.54
52-Wochen-Spanne:
Value
$1.20
$6.10

Cibus Inc Stock (CBUS) Company Profile

Name
Firmenname
Cibus Inc
Name
Telefon
(858) 450-0008
Name
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Name
Mitarbeiter
159
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
CBUS's Discussions on Twitter

Vergleichen Sie CBUS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CBUS
Cibus Inc
1.40 78.81M 1.82M -267.63M -50.53M -20.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Cibus Inc Stock (CBUS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-29 Eingeleitet Alliance Global Partners Buy
2024-07-19 Fortgesetzt Canaccord Genuity Buy
2023-10-09 Eingeleitet H.C. Wainwright Buy
2023-07-19 Fortgesetzt Canaccord Genuity Buy

Cibus Inc Aktie (CBUS) Neueste Nachrichten

pulisher
Oct 10, 2025

Sentiment analysis tools applied to Cibus Inc.Market Rally & Scalable Portfolio Growth Methods - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What’s next for Cibus Inc. stock pricePortfolio Gains Summary & Low Risk High Win Rate Picks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Tick level data insight on Cibus Inc. volatilityPortfolio Value Summary & Weekly Chart Analysis and Trade Guides - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Cibus Inc. recovery potential after sell offJuly 2025 Gainers & Community Supported Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Cibus' (CBUS) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

How to recover losses in Cibus Inc. stockJuly 2025 Pullbacks & Weekly Market Pulse Updates - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can Cibus Inc. stock deliver sustainable ROEJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Institutional scanner results for Cibus Inc.Market Volume Summary & Low Risk Profit Maximizing Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Head to Head Contrast: Corteva (NYSE:CTVA) versus Cibus (NASDAQ:CBUS) - Defense World

Oct 09, 2025
pulisher
Oct 09, 2025

Intraday pattern recognizer results for Cibus Inc.July 2025 Opening Moves & Low Risk Investment Opportunities - newser.com

Oct 09, 2025
pulisher
Oct 05, 2025

Why Cibus Inc. is moving today2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Tools to assess Cibus Inc.’s risk profile2025 Top Gainers & Smart Allocation Stock Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Using Ichimoku Cloud for Cibus Inc. technicalsJuly 2025 Update & Technical Pattern Alert System - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How sentiment analysis helps forecast Cibus Inc.Market Growth Summary & Weekly Top Gainers Trade List - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Cibus Completes Field Testing of Second-Generation Herbicide Tolerance Canola - iGrow News

Oct 03, 2025
pulisher
Oct 02, 2025

Cibus completes field testing of second-gen herbicide tolerance edited Canola - TipRanks

Oct 02, 2025
pulisher
Oct 02, 2025

Cibus (CBUS) Advances Canola Field Trials with Promising Results - GuruFocus

Oct 02, 2025
pulisher
Oct 02, 2025

Cibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited Canola - The Manila Times

Oct 02, 2025
pulisher
Oct 02, 2025

Cibus, Inc. Announces Successful Field Testing of HT2 Herbicide Tolerance Trait in Canola for Commercial Licensing - Quiver Quantitative

Oct 02, 2025
pulisher
Oct 02, 2025

Next-Gen Herbicide Tolerance: Cibus's Gene-Edited Canola Breakthrough Promises Better Weed Control - Stock Titan

Oct 02, 2025
pulisher
Oct 01, 2025

Using flow based indicators on Cibus Inc.Treasury Yields & High Accuracy Trade Signal Alerts - newser.com

Oct 01, 2025
pulisher
Sep 28, 2025

Cibus director Prante Gerhard sells $2,898 in stock - MSN

Sep 28, 2025
pulisher
Sep 28, 2025

Is Cibus Inc a good long term investmentMACD Trading Signals & Outstanding Investment Trading - earlytimes.in

Sep 28, 2025

Finanzdaten der Cibus Inc-Aktie (CBUS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Cibus Inc-Aktie (CBUS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Prante Gerhard
Director
Feb 24 '25
Sale
2.07
1,150
2,380
8,857
Prante Gerhard
Director
Feb 21 '25
Sale
2.20
1,150
2,530
10,007
Prante Gerhard
Director
Feb 20 '25
Sale
2.35
1,150
2,702
11,157
Prante Gerhard
Director
Feb 19 '25
Sale
2.58
1,150
2,967
12,307
Prante Gerhard
Director
Feb 18 '25
Sale
2.52
2,300
5,796
13,457
Prante Gerhard
Director
Feb 14 '25
Sale
2.60
1,150
2,990
15,757
Prante Gerhard
Director
Feb 13 '25
Sale
2.53
1,150
2,910
16,907
Prante Gerhard
Director
Feb 12 '25
Sale
2.45
1,150
2,818
18,057
Prante Gerhard
Director
Feb 11 '25
Sale
2.48
1,150
2,852
19,207
Prante Gerhard
Director
Feb 10 '25
Sale
2.52
1,150
2,898
20,357
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):